Related Content
Innovation
New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
PR-M06-18-NI-030
Innovation
Partnerships Between Bayer and DoE Formed to Produce Radioactive Pharma Intermediate
PAO-M06-18-NI-003
Contributing Authors
Peter Cramer, AIA, NCARB, LEED AP, is VP Life Science Facility Design at M+W Group with more than 25 years of industry-leading experience in preparing conceptual and basis of design documents for pharmaceutical and biologics clients. He is a leader in designing cGMP-manufacturing facilities for clients around the globe. A facility design subject matter expert and contributing member to ISPE, Peter is a thought leader who specializes in the planning and design of facilities using disposable-single-use and modular technologies.
